Qualigen Therapeutics enters waiver with Alpha Capital to pay October 2023 debenture redemption in shares

AIxCrypto Holdings, Inc.

Waiver applies to $3.3M 8% Senior Convertible Debenture issued Dec 22, 2022.
Alpha consents to paying the October 2023 Monthly Redemption Amount in Conversion Shares.
Alpha waives the Equity Conditions requirement for the October Payment.
No other terms of the Debenture are amended.
Effective September 22, 2023.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AIxCrypto Holdings, Inc. entered into Waiver with Alpha Capital Anstalt valued at $3,300,000 (effective 2023-09-22).

Action: entry
Agreement: notes offering
Counterparty: Alpha Capital Anstalt
Value: $3,300,000
Effective: 2023-09-22

Exact text from the filing

On September 22, 2023, Qualigen Therapeutics, Inc. (the “Company”) entered into a consent and waiver (the “Waiver”) with Alpha Capital Anstalt (“Alpha”) with respect to the 8% Senior Convertible Debenture in the aggregate principal amount of $3,300,000 issued by the Company to Alpha on December 22, 2022 (the “Debenture”).

View on SEC.gov

622 material agreements filed in the last 30 days. Browse all material agreements →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-034627

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.